Eric Karas, Chief Commercial Officer at ARS Pharmaceuticals, sold SPRY on Jun 12, 2026

Data as of Oct 27

▼ SELL$250K25,000 shares at $10.00Eric Karas Chief Commercial OfficerSPRY ARS Pharmaceuticals, Inc.

Watch SPRY

Traded: Jun 12, 2026
Disclosed: Jun 12, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

SPRYSimilar stocks (XLV — its sector index fund), rebased to SPRY's price on the disclosure day

SPRY since disclosure

−61.8%

after the sale

Similar stocks (XLV) since disclosure

+16.5%

XLV — its sector index fund

Change in closing price from Jun 12, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on SPRY →